|Articles|March 1, 2002
Allovectin-7 immunotherapy induces responses
Systemic answers offer needed care alternative in treatment of refractorymetastatic melanoma patients
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement














